Clinigen ought to help streamline Compassionate Use in both the UK, and in 16 EU nations not being supplied by Chime Biologics. It seems practically like Standard Operating Procedure for them. But I don't think it will be necessary for long.
I am super-excited about this current presentation, in which Humanigen, along with Lilly, are the only two Platinum Level Sponsors. Regeneron, Gilead, Pfizer, etc., are Silver Level Sponsors.
Not bad, for little-known Humanigen, who is focused on managing cash levels to the extent that significant portions of Q4 salaries are being paid in stock options.
I really want to see news of both an EUA and CMA come out of this.